» Articles » PMID: 33126952

Impact of the COVID-19 Pandemic on the Detection of TB in Shanghai, China

Overview
Specialty Pulmonary Medicine
Date 2020 Oct 31
PMID 33126952
Citations 28
Authors
Affiliations
Soon will be listed here.
Citing Articles

Assessing the impact of COVID-19 non-pharmaceutical interventions and relaxation policies on Class B respiratory infectious diseases transmission in China.

Wu N, Guan P, An S, Wang Z, Huang D, Ren Y Sci Rep. 2024; 14(1):21197.

PMID: 39261569 PMC: 11390917. DOI: 10.1038/s41598-024-72165-w.


Predicting the incidence of rifampicin resistant tuberculosis in Yunnan, China: a seasonal time series analysis based on routine surveillance data.

Yang Y, Liu L, Chen J, Li L, Qiu Y, Wu W BMC Infect Dis. 2024; 24(1):835.

PMID: 39152374 PMC: 11330134. DOI: 10.1186/s12879-024-09740-z.


The global impact of COVID-19 on tuberculosis: A thematic scoping review, 2020-2023.

Marco M, Ahmedov S, Castro K PLOS Glob Public Health. 2024; 4(7):e0003043.

PMID: 38959278 PMC: 11221697. DOI: 10.1371/journal.pgph.0003043.


Epidemiology and antimicrobial resistance of spp. in the United Arab Emirates: a retrospective analysis of 12 years of national antimicrobial resistance surveillance data.

Thomsen J, Abdulrazzaq N, Nyasulu P, Al Hosani F, Habous M, Weber S Front Public Health. 2024; 12:1244353.

PMID: 38947352 PMC: 11211529. DOI: 10.3389/fpubh.2024.1244353.


Impact of COVID-19 pandemic responses on tuberculosis incidence: insights from Shantou, China.

Su Y, Chang Q, Chen R, Chen Z, Lin J, Fu H BMC Public Health. 2024; 24(1):1454.

PMID: 38816699 PMC: 11140913. DOI: 10.1186/s12889-024-18956-2.